Jinxin Fertility Group Limited (abbreviated “JXR”) filed a Next Day Disclosure Return to the Hong Kong Stock Exchange on 27 March 2026, detailing the latest movements under its ongoing share-repurchase programme.

Share capital position • As of 27 March 2026, JXR maintained 2.74 billion issued ordinary shares (excluding treasury shares) and 13.00 million treasury shares, leaving total issued shares unchanged at 2.76 billion since the previous filing dated 28 February 2026.

Latest on-market repurchase • On 27 March 2026, the company bought back 3.52 million shares on the Exchange at prices between HK$2.26 and HK$2.31 per share, for an aggregate consideration of HK$8.05 million. • All shares acquired are designated for cancellation.

Cumulative repurchases pending cancellation • Including the most recent transaction, 43.18 million shares acquired between 5 December 2025 and 27 March 2026 remain outstanding for cancellation. • The cumulative volume represents 1.57% of the company’s issued share capital as at the date of the repurchase mandate.

Repurchase mandate utilisation • The current mandate, approved on 26 June 2025, allows the repurchase of up to 274.47 million shares. • After accounting for the 43.18 million shares already bought, 231.29 million shares—or 84.27% of the authorised limit—remain available for future repurchases. • In accordance with listing rules, JXR is subject to a moratorium on issuing new shares or selling treasury shares until 26 April 2026.